Diffusing capacity for carbon monoxide (DLCO) change and outcome in advanced non-small cell lung cancer (aNSCLC) treated with immune checkpoint inhibitors (ICIs).

Authors: Angela Montes, Alfredo Sanchez, Maria Arnal Rondán, Sara Cases, Jorge Soler, Isabel Tena, Blanca Navarro, Daiana Timacheva, Manuel Modesto, David Lorente

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20602

Source: Full article

---

Abstract

e20602